Browsing: HCP Access Only 1

Youth-onset Type 2 Diabetes: West vs Asia

By Tony ZhangMarch 17, 20230

In recent years, studies have shown an increasing number of children, adolescents and young adults being diagnosed with type 2 diabetes

FDA Approves Xenoview for Use with MRI for the Evaluation of Lung Ventilation

By KayeJanuary 27, 20230

In Dec 2022, Xenoview™, a hyperpolarized contrast agent prepared from a proprietary Xenon 129Xe Gas Blend, received FDA approval

FDA Approves Ublituximab for Relapsing Forms of Multiple Sclerosis

By KayeJanuary 20, 20230

In Dec 2022, the FDA approved BRIUMVI™, a chimeric monoclonal antibody (mAb) labelled for the treatment of RMS

FDA approves lenacapavir (Sunleca®) in heavily pre-treated adults with multi-drug resistant HIV-1 infection

By KayeJanuary 13, 20230

Lenacapavir (Sunleca®), a first-in-class long-acting HIV-1 capsid function inhibitor, was approved by the FDA in December 2022

A New Paradigm in Severe Burn Treatment – FDA Approves Anacaulase (NexoBrid®)

By KayeJanuary 3, 20230

In Dec 2022, the US Food and Drug Administration (FDA) approved MediWound’s biologic license application (BLA) for anacaulase-bcdb (NexoBrid®)

Indonesia To Launch Takeda’s QDENGA Dengue Vaccine Jab in 2023

By MCA TeamDecember 9, 20220

QDENGA, a live-attenuated, dengue tetravalent vaccine, was approved by Indonesia’s BPOM for the prevention of dengue caused by any serotype.

Breakthrough Therapy: What You Need to Know about HIBRUKA (Orelabrutinib)

By MCA TeamDecember 9, 20220

InnoCare Pharma announced the approval of HIBRUKA (Orelabrutinib) by the HSA of Singapore for the treatment of adult patients with r/r MCL

Smoking Cessation: It’s all about the Questions – 5A’s and 5R’s

By ShanPingNovember 25, 20221

Terlivaz (Terlipressin) to Improve Kidney Function in Adults with Hepatorenal Syndrome

By KayeNovember 17, 20220

Evidence for Smoking Cessation after Cardiovascular Events – Part 2

By Rachel TanNovember 3, 20220

Two recent studies examined the effects of smoking cessation after cardiovascular events. One found quitters halved their odds of recurrent heart attack within 6 months. The other recorded indistinguishable mortality risks for quitters and nonsmokers after 4 years, whereas persistent smoking was associated with double the mortality risk.

Copyright © Medical Channel Asia 2024. All rights reserved.
The contents on Medical Channel Asia are for general educational purposes only.
It is not intended to be a substitute for professional medical advice, treatment, or diagnosis.
See additional information.

What's Hot

Tun Dr Mahathir Hospitalised for Lung Infection at Heart Institute

Sunscreens: Topical or Oral?

“It’s Better to Know Early”: Malay Women in Singapore Face Lowest Breast Cancer Screening Rates

Browsing: HCP Access Only 1

Youth-onset Type 2 Diabetes: West vs Asia

FDA Approves Xenoview for Use with MRI for the Evaluation of Lung Ventilation

FDA Approves Ublituximab for Relapsing Forms of Multiple Sclerosis

FDA approves lenacapavir (Sunleca®) in heavily pre-treated adults with multi-drug resistant HIV-1 infection

A New Paradigm in Severe Burn Treatment – FDA Approves Anacaulase (NexoBrid®)

Indonesia To Launch Takeda’s QDENGA Dengue Vaccine Jab in 2023

Breakthrough Therapy: What You Need to Know about HIBRUKA (Orelabrutinib)

Smoking Cessation: It’s all about the Questions – 5A’s and 5R’s

Terlivaz (Terlipressin) to Improve Kidney Function in Adults with Hepatorenal Syndrome

Evidence for Smoking Cessation after Cardiovascular Events – Part 2

Tun Dr Mahathir Hospitalised for Lung Infection at Heart Institute

Sunscreens: Topical or Oral?

“It’s Better to Know Early”: Malay Women in Singapore Face Lowest Breast Cancer Screening Rates

Mammograms: The Most Reliable Detector of Breast Cancer

Subscribe to Updates

What's Hot

Browsing: HCP Access Only 1

Subscribe to Updates